FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy

Dickran Kazandjian, Richard Pazdur, Daniel L. Suzman et al.|The Oncologist|2016

Cited by 478